Page last updated: 2024-09-03

reboxetine and Sleep Apnea, Obstructive

reboxetine has been researched along with Sleep Apnea, Obstructive in 4 studies

*Sleep Apnea, Obstructive: A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395) [MeSH]

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Azarbarzin, A; Lombardi, C; Marconi, M; Meriggi, P; Parati, G; Perger, E; Rosa, D; Sands, SA; Taranto Montemurro, L; Vicini, S; Wellman, A; Zanotti, L1
Azarbarzin, A; Baratto, C; Caravita, S; Castiglioni, P; Faini, A; Lombardi, C; Meriggi, P; Parati, G; Perger, E; Pini, L; Rosa, D; Soranna, D; Vicini, S; Zambon, A1
Bayon, V; Berger, M; Bradley, B; Dussez, R; Haba-Rubio, J; Heiniger, G; Heinzer, R; Lecciso, G; Marchi, NA; Siclari, F; Solelhac, G; Van Den Broecke, S1
Carberry, JC; Eckert, DJ; Grunstein, R; Lim, R; Wellman, A1

Trials

4 trial(s) available for reboxetine and Sleep Apnea, Obstructive

ArticleYear
Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
    Chest, 2022, Volume: 161, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Polysomnography; Reboxetine; Severity of Illness Index; Sleep Apnea, Obstructive; Treatment Outcome

2022
Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation.
    Scientific reports, 2023, 02-23, Volume: 13, Issue:1

    Topics: Autonomic Nervous System; Blood Pressure Monitoring, Ambulatory; Heart Rate; Humans; Middle Aged; Reboxetine; Sleep Apnea, Obstructive

2023
Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial.
    Sleep, 2023, 07-11, Volume: 46, Issue:7

    Topics: Cross-Over Studies; Double-Blind Method; Humans; Male; Oxygen; Reboxetine; Sleep Apnea, Obstructive

2023
Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals.
    Sleep, 2019, 04-01, Volume: 42, Issue:4

    Topics: Adult; Airway Resistance; Australia; Butylscopolammonium Bromide; Cross-Over Studies; Double-Blind Method; Electromyography; Female; Humans; Male; Nose; Parasympatholytics; Pharyngeal Muscles; Pharynx; Polysomnography; Pressure; Reboxetine; Respiration; Scopolamine; Sleep; Sleep Apnea, Obstructive; Sleep, REM; Tongue; Wakefulness

2019